Pharmacology: Screening inhibitors of anthrax lethal factor

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature

• Publication date

  2002-07-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/418386aPMID 12140548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quickening the pace of anthrax research: three advances point towards possible therapies.

  2002cited by this paper
• Microbiology: Tackling anthrax

  2001cited by this paper
• Crystal structure of the anthrax lethal factor

  2001cited by this paper
• Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

  2000cited by this paper
• Protein transduction: unrestricted delivery into all cells?

  2000cited by this paper
• Novel approaches to targeting neuropeptide systems.

  2000cited by this paper
• Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.

  1998cited by this paper
• Anthrax pathogenesis and host response.

  1998cited by this paper
• Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

  1998cited by this paper
• Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

  1986cited by this paper

• Control of metalloenzyme activity using photopharmacophores.

  2024cites this paper
• Label-free high-precise nanopore detection of endopeptidase activity of anthrax lethal factor regulated by diverse conditions.

  2022cites this paper
• Skin and soft tissue infections

  2021cites this paper
• Inhibition of Pore-Forming Proteins

  2019cites this paper
• Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor.

  2018cites this paper
• Targeting Metalloenzymes for Therapeutic Intervention.

  2018cites this paper
• Inhibition of anthrax lethal factor by ssDNA aptamers.

  2018cites this paper
• An investigation of the pH dependence of copper-substituted anthrax lethal factor and its mechanistic implications.

  2018cites this paper
• Design and use of a novel substrate for simple, rapid, and specific early detection of anthrax infection

  2018cites this paper
• Chemical Strategies To Target Bacterial Virulence.

  2017cites this paper
• Examining sedentary time as a risk factor for cardiometabolic diseases and their markers in South Asian adults: a systematic review

  2017cites this paper
• The influence of pH and chemical denaturants on metal binding and structure of anthrax lethal factor

  2017cites this paper
• Drug Resistant Bacterial Pathogens and Their Threat Level to Society According to the Centers for Disease Control and Prevention

  2017cites this paper
• Anti-virulence Strategies to Target Bacterial Infections.

  2016cites this paper
• Inhibitors of the Metalloproteinase Anthrax Lethal Factor.

  2016cites this paper
• Studies on metal exchange and inhibition in anthrax lethal factor

  2016cites this paper
• Botulinum Neurotoxin, Tetanus Toxin, and Anthrax Lethal Factor Countermeasures

  2016cites this paper
• Bacillus anthracis toxins

  2015cites this paper
• Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamase.

  2015cites this paper
• Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.

  2015cites this paper
• An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis

  2015cites this paper
• Influence of chemical denaturants on the activity, fold and zinc status of anthrax lethal factor

  2015cites this paper
• Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?

  2015cites this paper
• Effects of metalloprotease anthrax lethal factor on its peptide-based inhibitor R9LF-1

  2015cites this paper
• Simulations of Chemical Catalysis

  2014cites this paper
• DEVELOPMENT AND KINETIC MODELING OF MULTIPLEX MICROSPHERE ASSAYS FOR HIGH-THROUGHPUT DISCOVERY OF PROTEASE ACTIVE SMALL MOLECULE COMPOUNDS

  2014cites this paper
• THE INHIBITION OF THE VIM-2 AND IMP-1 METALLO-β-LACTAMASES BY CATIONIC PEPTIDES

  2014cites this paper
• Structure-based pharmacophore modeling and virtual screening to identify novel inhibitors for anthrax lethal factor

  2014cites this paper
• Anthrax lethal factor inhibitors as potential countermeasure of the infection.

  2014cites this paper
• Identification of toxin inhibitors using a magnetic nanosensor-based assay.

  2014cites this paper
• Designing inhibitors of anthrax toxin

  2014cites this paper
• Small molecule inhibitors of anthrax lethal factor toxin.

  2014cites this paper
• High metal substitution tolerance of anthrax lethal factor and characterization of its active copper-substituted analogue.

  2014cites this paper
• Designed Azolopyridinium Salts Block Protective Antigen Pores In Vitro and Protect Cells from Anthrax Toxin

  2013cites this paper
• Effect of pH on the catalytic function and zinc content of native and immobilized anthrax lethal factor

  2013cites this paper
• Anthrax vaccines: present status and future prospects

  2013cites this paper
• Functionalized gold nanoparticle supported sensory mechanisms applied in detection of chemical and biological threat agents: a review.

  2012cites this paper
• Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.

  2012cites this paper
• Assessment Of Molecular Interactions Via Magnetic Relaxation: A Quest For Inhibitors Of The Anthrax Toxin

  2012cites this paper
• Bacterial proteases in disease - role in intracellular survival, evasion of coagulation/ fibrinolysis innate defenses, toxicoses and viral infections.

  2012cites this paper
• Development of a Comprehensive, Validated Pharmacophore Hypothesis for Anthrax Toxin Lethal Factor (LF) Inhibitors Using Genetic Algorithms, Pareto Scoring, and Structural Biology

  2012cites this paper
• Inhibition of anthrax lethal factor: lability of hydroxamate as a chelating group

  2012cites this paper
• Investigation of the pH dependent conformational changes of anthrax protective antigen and interactions with its cellular receptor

  2011cites this paper
• Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.

  2011cites this paper
• Subsite specificity of anthrax lethal factor and its implications for inhibitor development.

  2011cites this paper
• Characterization of MtfA, a Novel Regulatory Output Signal Protein of the Glucose-Phosphotransferase System in Escherichia coli K-12

  2011cites this paper
• Preparation and characterization of cobalt-substituted anthrax lethal factor.

  2011cites this paper
• Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax.

  2011cites this paper
• ighting bacterial infections — Future treatment options

  2011cites this paper
• Characterization of MtfA , a novel regulatory output signal protein of the 1 glucose-phosphotransferase system in E . coli K-12 2 3

  2011cites this paper
• The global need for effective antibiotics-a summary of plenary presentations.

  2011cites this paper
• Fighting bacterial infections-future treatment options.

  2011cites this paper
• The global need for effective antibiotics-moving towards concerted action.

  2011cites this paper
• Quantum mechanical/molecular mechanical study of anthrax lethal factor catalysis

  2011cites this paper
• Diamidodipyrrins as BODIPY dyes and chelator fragment libraries to identify new scaffolds for metalloprotein inhibitors

  2010cites this paper
• Residue Histidine 669 Is Essential for the Catalytic Activity of Bacillus anthracis Lethal Factor

  2010cites this paper
• Alkaline earth metals are not required for the restoration of the apoform of anthrax lethal factor to its holoenzyme state.

  2010cites this paper
• Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde

  2009cites this paper
• The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

  2009cites this paper
• Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.

  2009cites this paper
• Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay.

  2009cites this paper
• Identification of Novel Non-Hydroxamate Anthrax Toxin Lethal Factor Inhibitors by Topomeric Searching, Docking and Scoring, and in Vitro Screening

  2009cites this paper
• Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.

  2009cites this paper
• Anthrax toxin: pathologic effects on the cardiovascular system.

  2009cites this paper
• Microsphere based protease assays and high throughput screening of bacterial toxin proteases

  2009cites this paper
• Substrate Recognition of Anthrax Lethal Factor Examined by Combinatorial and Pre-steady-state Kinetic Approaches*

  2009cites this paper
• Novel strategies to combat bacterial virulence

  2008cites this paper
• The biology and future prospects of antivirulence therapies

  2008cites this paper
• Low molecular weight inhibitors of the protease anthrax lethal factor.

  2008cites this paper
• Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.

  2008cites this paper
• Discovery and development of anthrax lethal factor metalloproteinase inhibitors.

  2008cites this paper
• Bacillus anthracis: Balancing innocent research with dual-use potential

  2008cites this paper
• New Candidate Anthrax Pathogenic Factors

  2008cites this paper
• New insights into the pathogenesis and treatment of anthrax toxin-induced shock

  2007cites this paper
• Inhibitors of anthrax lethal factor.

  2007cites this paper
• The Design of Inhibitors for Medicinally Relevant Metalloproteins

  2007cites this paper
• High-Affinity, Human Antibody-Like Antibody Fragment (Single-Chain Variable Fragment) Neutralizing the Lethal Factor (LF) of Bacillus anthracis by Inhibiting Protective Antigen-LF Complex Formation

  2007cites this paper
• Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease.

  2007cites this paper
• Mechanistic differences between in vitro assays for hydrazone-based small molecule inhibitors of anthrax lethal factor.

  2007cites this paper
• Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.

  2007cites this paper
• Quantitative inhibitor fingerprinting of metalloproteases using small molecule microarrays.

  2007cites this paper
• Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.

  2006cites this paper
• Evaluation and Binding‐Mode Prediction of Thiopyrone‐Based Inhibitors of Anthrax Lethal Factor

  2006cites this paper
• Gold nanoparticles-based protease assay.

  2006cites this paper
• Microsphere‐based protease assays and screening application for lethal factor and factor Xa

  2006cites this paper
• Evaluation of the Protective Effects of Quinacrine Against Bacillus anthracis Ames

  2006influential citation
• CHAPTER 18 – Bacillus anthracis toxins

  2006cites this paper
• ANTHRAX LETHAL FACTOR: CRITICAL VIRULENCE FACTOR OF PATHOGENESIS OF ANTHRAX TOXINS

  2006cites this paper
• Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.

  2006cites this paper
• Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.

  2006cites this paper
• Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor.

  2005cites this paper
• The evolving field of biodefence: therapeutic developments and diagnostics

  2005influential citation
• Inter-Alpha-Inhibitor Proteins Are Endogenous Furin Inhibitors and Provide Protection against Experimental Anthrax Intoxication

  2005cites this paper
• Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences.

  2005cites this paper
• Development of high-throughput assay of lethal factor using native substrate.

  2005cites this paper
• Biowarfare Pathogens. Is the Research Flavor Different Than That of Clinically Relevant Pathogens?

  2004cites this paper
• The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor

  2004cites this paper
• Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor

  2004cites this paper
• Anthrax toxins.

  2004cites this paper
• Antitoxins: novel strategies to target agents of bioterrorism

  2004cites this paper